Sonoma Pharmaceuticals, Inc. announced on August 13, 2025, the launch of its HOCl-based diaper rash product for infants and children into large retailers across the United States. This includes distribution through Walmart.
The antimicrobial hydrogel product is being marketed and sold through Sonoma's U.S.-based distribution partner. This strategic move expands Sonoma's product portfolio into the pediatric care segment.
This launch into major retail channels represents a significant commercial opportunity, leveraging established distribution networks to reach a broad consumer base in the U.S. market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.